(Q36714897)

15 August 2017

1 reference

title

Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane (English)

1 reference

15 August 2017

3 Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane (English)

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

9 November 2022

1

M. J. Telen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724205

9 November 2022

author name string

W. F. Rosse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724205

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1724205

9 November 2022

publication date

1 December 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:S0950353606800338?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

https://api.elsevier.com/content/article/PII:S0950353606800338?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Best Practice and Research: Clinical Haematology

9 November 2022

published in

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

849-868

1 reference

Membrane proteins related to anion permeability of human red blood cells. I. Localization of disulfonic stilbene binding sites in proteins involved in permeation

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Signal peptide for protein secretion directing glycophospholipid membrane anchor attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Signal for attachment of a phospholipid membrane anchor in decay accelerating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Analysis of the signal for attachment of a glycophospholipid membrane anchor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Glycolipid anchoring of plasma membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

A possible null phenotype in the Cromer blood group complex

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Isolation of decay accelerating factor (DAF) by a two-step procedure and determination of its N-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Chronic Hemolytic Anemia with Paroxysmal Nocturnal Hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Paroxysmal Nocturnal Hemoglobinuria (PNH) as a Clonal Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The Lysis of Paroxysmal Nocturnal Haemoglobinuria Red Cells by Serum and Cobra Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Membrane-associated NAD+ glycohydrolase from rabbit erythrocytes is solubilized by phosphatidylinositol-specific phospholipase C

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Structural and functional roles of glycosyl-phosphatidylinositol in membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

A "new" phenotype confirming a relationship between Cra and Tca

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

A second Dr(a-) proposita with anti-Dra and a family with the Dr(a-) phenotype in two generations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Exclusion of unassigned blood group system loci from the regulator of complement activation gene cluster on chromosome 1q32

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Isolation and Expression of the Full-Length cDNA Encoding CD59 Antigen of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Improved method for the isolation and preliminary characterization of human DAF (decay-accelerating factor)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Analysis of PI (phosphatidylinositol)-anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement-regulatory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2806%2980033-8

7 January 2021

The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria

1

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein

9 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation

9 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Diagnostic specificity of sucrose hemolysis test for paroxysmal nocturnal hemoglobinuria

9 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions

9 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations

9 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor

9 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

9 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system

9 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF)

9 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo

9 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Structure of the gene for human complement protein decay accelerating factor

9 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9

9 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3

9 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells

9 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage

9 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/S0950-3536(06)80033-8

9 November 2022

Identifiers

1 reference

15 August 2017

1 reference